Neuroscience

Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-   B7258 A 841720Summary: mGluR1 antagonist, non-competitive B7258 A 841720Summary: mGluR1 antagonist, non-competitive
-   B7655 JHW 007 hydrochlorideSummary: Dopamine uptake inhibitor B7655 JHW 007 hydrochlorideSummary: Dopamine uptake inhibitor
-   B7234 MMPIP hydrochlorideSummary: allosteric mGlu7-selective receptor antagonist B7234 MMPIP hydrochlorideSummary: allosteric mGlu7-selective receptor antagonist
-   B6351 BP 554 maleateSummary: Selective 5-HT1A agonist B6351 BP 554 maleateSummary: Selective 5-HT1A agonist
-   B7607 SonepiprazoleSummary: rat and human dopamine D4 receptor antagonist B7607 SonepiprazoleSummary: rat and human dopamine D4 receptor antagonist
-   B7578 Flupenthixol dihydrochlorideSummary: Antipsychotic drug,exhibits antagonistic activity at dopamine D1-5 receptors B7578 Flupenthixol dihydrochlorideSummary: Antipsychotic drug,exhibits antagonistic activity at dopamine D1-5 receptors
-   B6349 NAN-190 hydrobromideSummary: 5-HT1A antagonist B6349 NAN-190 hydrobromideSummary: 5-HT1A antagonist
-   B7217 Ro 64-5229Summary: mGlu2 antagonist B7217 Ro 64-5229Summary: mGlu2 antagonist
-   B7095 L-BMAA hydrochlorideSummary: Neurotoxic glutamate agonist B7095 L-BMAA hydrochlorideSummary: Neurotoxic glutamate agonist
-   B7562 NPEC-caged-dopamineSummary: Dopamine receptor agonist B7562 NPEC-caged-dopamineSummary: Dopamine receptor agonist
